{
  "directed": true,
  "multigraph": true,
  "graph": {
    "pybel_version": "0.13.1",
    "document_metadata": {
      "copyright": "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved.",
      "licenses": "Private Ownership to Fraunhofer Institute SCAI",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "name": "B-973, a novel piperazine positive allosteric modulator of the α7 nicotinic acetylcholine receptor",
      "version": "1.0.0",
      "authors": "Sandra Spalek",
      "description": ""
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "HBP": "https://raw.githubusercontent.com/pharmacome/terminology/77c0796c3ca82a80cb0eaf1c8380d6ccd7f323af/export/hbp-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/external/hgnc.genefamily-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/01c9daa61012b37dd0a1bc962521ba51a15b38f1/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns",
      "MIRBASE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mirbase-names.belns",
      "NCBIGENE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns",
      "PFAM": "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns",
      "RGD": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "CTO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/clinical-trial-ontology/clinical-trial-ontology-1.0.0.belns",
      "DO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20170725.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
      "SCOMP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20170725.belns",
      "SFAM": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20170725.belns"
    },
    "namespace_pattern": {
      "DBSNP": "rs[0-9]+",
      "TAXONOMY": "^\\d+$",
      "UNIPROT": "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\\.\\d+)?$",
      "PUBCHEM": "^\\d+$"
    },
    "namespaces_uncached": [],
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "Gender": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_list": {},
    "path": "/Users/cthoyt/dev/hbp-knowledge/hbp_knowledge/post-munson2017.bel"
  },
  "nodes": [
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "1-(5-chloro-2,4-dimethoxyphenyl)-3-(5-methyl-3-isoxazolyl)urea",
      "id": "059e301c877f4e7ca32bf349000c28379627fb6d8f14ef5c5af14d66b0c2cf33aa7d607793e587becc85a58e38a8f7d6532c869fff5a8b4c477dd8713918ac45"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "acetylcholine",
      "id": "bae5841bb74f1e9eb73cd433cda657927031217c24e17f21bb2975128d1d9be4dc899448ede71d9aa18224145a1681b90b33287454eabf938f405bc1b8894b62"
    },
    {
      "function": "Abundance",
      "namespace": "CHEBI",
      "name": "epibatidine",
      "id": "8fa881896eaa3aadba5ff12130ddcc6eca42fcf2a2ca6719d07a59368a7601b74b796b0b98a3a97fa9640738e47eb39041cf058f925b984f219a2086c67502cf"
    },
    {
      "function": "Abundance",
      "namespace": "GO",
      "name": "membrane",
      "id": "09305a501cf3bf7a45ecb4a391b757c0608c849562404df8ccaf5fa0f6d76dd5598dc0d1c9c8e6e81321e583573b3b88f512123c22e62dc747cfc499a822e3cc"
    },
    {
      "function": "Abundance",
      "namespace": "HBP",
      "name": "B-973",
      "id": "4a3aceeb691f94812bf37e4beee656c77769751674da83ea937f331e5664697287a8ffb8d37c0b4a818947566550d26a31ce1eba06b8e27c915ae2b83a611a68"
    },
    {
      "function": "Abundance",
      "namespace": "MESH",
      "name": "alpha7 Nicotinic Acetylcholine Receptor",
      "id": "24bfa0a4dedd705b999b510936aa1c989978fdeec807bf3046bd5178bd8e69ebbf2b1d2d2cd30ce5df8058656f59f497172cea193c9743a405bfb38be1aac50b"
    },
    {
      "function": "Abundance",
      "namespace": "PUBCHEM",
      "name": "16068384",
      "id": "bc7c25d3efc6bf64a8fe5695517fc6ad742bc5ead3f53ac09a17699698f64f4959783cafacccb0b1ffa41c12b2a0434e748c2009a2320f5f8eab6af40360badd"
    },
    {
      "function": "Abundance",
      "namespace": "PUBCHEM",
      "name": "5288811",
      "id": "e7b320723ad1cf04389d8bfd5310cca17844b7ada93adaf4b44393ca7e3bb453de20e4551c7d00ada3096770f9434ea5a3b9e6ffba13103a6df5c0b91d40338f"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Abundance",
          "namespace": "GO",
          "name": "membrane",
          "id": "09305a501cf3bf7a45ecb4a391b757c0608c849562404df8ccaf5fa0f6d76dd5598dc0d1c9c8e6e81321e583573b3b88f512123c22e62dc747cfc499a822e3cc"
        },
        {
          "function": "Abundance",
          "namespace": "PUBCHEM",
          "name": "16068384",
          "id": "bc7c25d3efc6bf64a8fe5695517fc6ad742bc5ead3f53ac09a17699698f64f4959783cafacccb0b1ffa41c12b2a0434e748c2009a2320f5f8eab6af40360badd"
        }
      ],
      "id": "00c8f53d7a17ee33d74dd074b81a83027171836bd329f2f87dd8775e06a0a61256f7684b87a50ec785a43f1b765d40224469c2b83466db88058a1337715bb5c8"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Abundance",
          "namespace": "MESH",
          "name": "alpha7 Nicotinic Acetylcholine Receptor",
          "id": "24bfa0a4dedd705b999b510936aa1c989978fdeec807bf3046bd5178bd8e69ebbf2b1d2d2cd30ce5df8058656f59f497172cea193c9743a405bfb38be1aac50b"
        },
        {
          "function": "Abundance",
          "namespace": "PUBCHEM",
          "name": "16068384",
          "id": "bc7c25d3efc6bf64a8fe5695517fc6ad742bc5ead3f53ac09a17699698f64f4959783cafacccb0b1ffa41c12b2a0434e748c2009a2320f5f8eab6af40360badd"
        }
      ],
      "id": "7bf39458e6a4448b83348dfe4d95e430b03d5e24badc4d03733a19eac33506adc0208116cbe003b70cfec576de23301ac66ef5b4b61cf5abd6a2fbad37a3c9f4"
    },
    {
      "function": "Complex",
      "members": [
        {
          "function": "Abundance",
          "namespace": "PUBCHEM",
          "name": "16068384",
          "id": "bc7c25d3efc6bf64a8fe5695517fc6ad742bc5ead3f53ac09a17699698f64f4959783cafacccb0b1ffa41c12b2a0434e748c2009a2320f5f8eab6af40360badd"
        },
        {
          "function": "Protein",
          "namespace": "MGI",
          "name": "Chrna7",
          "id": "507ee2a4a31335902e30c31717eb51a26ee9f31d8e015d2cc3beb6961c3c386edb03a4ac82b8c0c0ee38319e2f43609932215b67a7fb2b3e4a496eda6f99f478"
        }
      ],
      "id": "15bc0af69acb10ae10f6d7f89d6daeec58107a8ccff400dc3b2f866a24ae0b44bba06ba89be25f514ee411b9b165c86103f433166adf98fd5bbc423012e89642"
    },
    {
      "function": "Protein",
      "namespace": "MGI",
      "name": "Chrna7",
      "id": "507ee2a4a31335902e30c31717eb51a26ee9f31d8e015d2cc3beb6961c3c386edb03a4ac82b8c0c0ee38319e2f43609932215b67a7fb2b3e4a496eda6f99f478"
    }
  ],
  "links": [
    {
      "line": 88,
      "relation": "increases",
      "evidence": "Peak current was increased 2-fold and 6-fold relative to 3 mM acetylcholine in 300 nM and 1 μM B-973, respectively (Fig. 1C)",
      "citation": {
        "type": "PubMed",
        "name": "Eur J Pharmacol. 2017 Mar 15;799:16-25. doi: 10.1016/j.ejphar.2017.01.037",
        "reference": "28132910"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 4,
      "target": 5,
      "key": "2f9211d8d15d377bd2faab61bfa813b28e1b97525325f3babe6aee165d463241299726df267b29231a0c1dddf25dea66dd6385e3c47e4737affe93f5141c3bf3"
    },
    {
      "line": 97,
      "relation": "negativeCorrelation",
      "evidence": "B-973 slows receptor deactivation dramatically (Fig. 4A)",
      "citation": {
        "type": "PubMed",
        "name": "Eur J Pharmacol. 2017 Mar 15;799:16-25. doi: 10.1016/j.ejphar.2017.01.037",
        "reference": "28132910"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 4,
      "target": 5,
      "key": "512f62c543ffbd2afe419e9a0842af594a37e75e42044eba885cbf261d6c24b3c4738f2a38477504279ca509a4cf7c30853bf9e6de3dc8074430344ce3a81ecb"
    },
    {
      "line": 127,
      "relation": "increases",
      "evidence": "The amplitude of currents were dose dependent, reaching levels at 30 μM B-973 larger than control currents in response to 3 mM acetylcholine (Fig. 7A)",
      "citation": {
        "type": "PubMed",
        "name": "Eur J Pharmacol. 2017 Mar 15;799:16-25. doi: 10.1016/j.ejphar.2017.01.037",
        "reference": "28132910"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 4,
      "target": 5,
      "key": "6f9ad524d1c23c1219e93a9743603bea32764c8bb265e2ce940eb85c6d219af6cb9bcd13d41db4c2fa19d31f314563d21edfb5b5fc993c418a75b1f4e3cb257b"
    },
    {
      "line": 131,
      "relation": "increases",
      "evidence": "The currents induced by B-973 alone arise from the α7 receptor since methyllycaconitine blocks them nearly completely (Fig. 7C and Fig. S6)",
      "citation": {
        "type": "PubMed",
        "name": "Eur J Pharmacol. 2017 Mar 15;799:16-25. doi: 10.1016/j.ejphar.2017.01.037",
        "reference": "28132910"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 4,
      "target": 5,
      "key": "be210ce9a524d35f3490564242a747ca4dedd11f684daed65ba42a8d0c6038482c5cc94ebb8c5cbd7367576870c9888e2aadcc0ec29fd731960e422a5ba85f9f"
    },
    {
      "line": 93,
      "relation": "increases",
      "evidence": "Over the concentration range studied, B-973 increased the potency of acetylcholine at the α7 receptor 70-fold (control acetylcholine EC50=0.49 mM; acetylcholine EC50 at 1 μM B-973=0.007 mM)",
      "citation": {
        "type": "PubMed",
        "name": "Eur J Pharmacol. 2017 Mar 15;799:16-25. doi: 10.1016/j.ejphar.2017.01.037",
        "reference": "28132910"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 4,
      "target": 1,
      "key": "d018f84c8a46781d38cc89e81149333330e71cf929e9279d3020a13f7ae9887e91b6e931db47e702b03d571fb1571fc7efa8c0b1a0b8063de082eaf28d33b77c"
    },
    {
      "line": 109,
      "relation": "increases",
      "evidence": "PNU-120596 and B-973 enhanced [3H]A-585539 binding to rat brain membranes (Fig. 5B,C)",
      "citation": {
        "type": "PubMed",
        "name": "Eur J Pharmacol. 2017 Mar 15;799:16-25. doi: 10.1016/j.ejphar.2017.01.037",
        "reference": "28132910"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "source": 4,
      "target": 8,
      "key": "d87420773fca10f7205ba10ad9a1d4f5d13b9fd353833901149651f6b7d303cee750f2af5bd4dcfffd0e1fc245983b9ba24b764fc2d60cc258fd5a9dfd4d3e7d"
    },
    {
      "line": 117,
      "relation": "increases",
      "evidence": "[3H]A-585539 saturation binding revealed that B-973 and PNU-120596 increased the affinity of the receptor for [3H]A-585539 approximately 4-fold without changing the apparent Bmax (Fig. 5D)",
      "citation": {
        "type": "PubMed",
        "name": "Eur J Pharmacol. 2017 Mar 15;799:16-25. doi: 10.1016/j.ejphar.2017.01.037",
        "reference": "28132910"
      },
      "source": 4,
      "target": 9,
      "key": "57e99078b5aa89d8276f65053910a23ca5ac8aeb83707d958f9fece4a77db42e61527c38312d8b964f0070bc4c1aa7e3243299f47df0f28859f3130a14806907"
    },
    {
      "line": 122,
      "relation": "increases",
      "evidence": "At the highest PAM concentration tested (10 μM), the percent increase in [3H]A-585539 binding was much greater for recombinant α7 than that observed with rat brain membranes",
      "citation": {
        "type": "PubMed",
        "name": "Eur J Pharmacol. 2017 Mar 15;799:16-25. doi: 10.1016/j.ejphar.2017.01.037",
        "reference": "28132910"
      },
      "source": 4,
      "target": 10,
      "key": "ddb8f5842eb5ce6ff3b5ec6b4aebab5ddd9dbffd3029f25927dead6bcabef7ed48bdf5955c05cf48d06129c5290d5daa64b75a4611a716352a3b1f9a70173f35"
    },
    {
      "line": 97,
      "relation": "negativeCorrelation",
      "evidence": "B-973 slows receptor deactivation dramatically (Fig. 4A)",
      "citation": {
        "type": "PubMed",
        "name": "Eur J Pharmacol. 2017 Mar 15;799:16-25. doi: 10.1016/j.ejphar.2017.01.037",
        "reference": "28132910"
      },
      "subject": {
        "modifier": "Activity"
      },
      "source": 5,
      "target": 4,
      "key": "2fc25a8b2f5d32f942eec8c987111e65af9131591297a55d4660d5097f3954d473e2eb295124b2447b869ca9b0b5a3d29d7d1b3a50d5af3f0cba29ac2f3c3823"
    },
    {
      "line": 102,
      "relation": "decreases",
      "evidence": "As expected, binding was inhibited by epibatidine (Fig. 5A)",
      "citation": {
        "type": "PubMed",
        "name": "Eur J Pharmacol. 2017 Mar 15;799:16-25. doi: 10.1016/j.ejphar.2017.01.037",
        "reference": "28132910"
      },
      "source": 2,
      "target": 9,
      "key": "07cde71d7e44d0b1088a23204e7bca6a7bdb3fdd4aa0e99a74e12ac7eaa60bb28f8b3929b9d989ebb046eda1f4bb63bdaeafb1a62142eb6b52c9970833e62573"
    },
    {
      "relation": "hasComponent",
      "source": 9,
      "target": 5,
      "key": "3a4dd2b2b8975f84142f356b84db6c7a358c1cf8072c11fc4b15ff09dfface1e90421cd253e2d7cac1e3b4af29cef46a7eeceef2fbd97bc47b7f8a1a5221d43a"
    },
    {
      "relation": "hasComponent",
      "source": 9,
      "target": 6,
      "key": "039787ea04bb96e69069d93068a77f3bc5d428e3d7f3a5213427285b02f3551cea0802cdd3ed00f2c80109df632ff628ee082ff85b159dfe590dda205f8678e1"
    },
    {
      "line": 108,
      "relation": "increases",
      "evidence": "PNU-120596 and B-973 enhanced [3H]A-585539 binding to rat brain membranes (Fig. 5B,C)",
      "citation": {
        "type": "PubMed",
        "name": "Eur J Pharmacol. 2017 Mar 15;799:16-25. doi: 10.1016/j.ejphar.2017.01.037",
        "reference": "28132910"
      },
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "source": 0,
      "target": 8,
      "key": "35b7888d0a4deb6353c7d42e1ba145ddbca144f70701127a4c70a033221d23fb20b96a1e59bf3a25f6c706247dbded376f450dc1c5e227cf51e28f0751bf5835"
    },
    {
      "line": 116,
      "relation": "increases",
      "evidence": "[3H]A-585539 saturation binding revealed that B-973 and PNU-120596 increased the affinity of the receptor for [3H]A-585539 approximately 4-fold without changing the apparent Bmax (Fig. 5D)",
      "citation": {
        "type": "PubMed",
        "name": "Eur J Pharmacol. 2017 Mar 15;799:16-25. doi: 10.1016/j.ejphar.2017.01.037",
        "reference": "28132910"
      },
      "source": 0,
      "target": 9,
      "key": "3315159a65d028e15c46ce127cb88185117b937b86e01d6a10b64c6d150f0d7c614fdc13f660f29e39d59ff9bda125476e12414960e84bed46dca5661dcb8c2a"
    },
    {
      "relation": "hasComponent",
      "source": 8,
      "target": 3,
      "key": "efb80d1e892c0c18d066c3c332ef7c1127952d0871abfc699481e1e09341524ccbbcf8669bb8914f52d8cf2646d4dad296d67af5b17cb1d5f77cb9d1e1914393"
    },
    {
      "relation": "hasComponent",
      "source": 8,
      "target": 6,
      "key": "fd01673bedb86f16c8a5e362d23274667812ebbd9ed1c3530583365ae4a49039f27f6eb6e1e3f1ed04caf87aeba06e9135f53c61086859a2449d919ee4d2a10f"
    },
    {
      "relation": "hasComponent",
      "source": 10,
      "target": 6,
      "key": "a415c32e25a4c22bf6dc3fbdc9dc25518b506d4578502b51c339e8bf317dfbbb2323a93c0988570c53926b09dae7f12584f2dd2f1d097843c5dd2bf543cd8560"
    },
    {
      "relation": "hasComponent",
      "source": 10,
      "target": 11,
      "key": "9462de75ae3ea0afb65518e2e7f9dc8b398d803fb927f2eb96615e215394e8129072a3de7ed1824b21668e6d5777400ed3d9eb7381a360b488e2e149ed535a49"
    },
    {
      "line": 132,
      "relation": "decreases",
      "evidence": "The currents induced by B-973 alone arise from the α7 receptor since methyllycaconitine blocks them nearly completely (Fig. 7C and Fig. S6)",
      "citation": {
        "type": "PubMed",
        "name": "Eur J Pharmacol. 2017 Mar 15;799:16-25. doi: 10.1016/j.ejphar.2017.01.037",
        "reference": "28132910"
      },
      "object": {
        "modifier": "Activity"
      },
      "source": 7,
      "target": 5,
      "key": "08a1635798eb2e79fd7f1509b41ca787f22a0f59f5639c18d0e257c15c6b1484b2caaf0e29dc7d4304b479ef37bd4fedd10d38a5fddec7a4d19d08c3b2617a02"
    }
  ]
}